AGP Executive Report
Last update: 4 hours agoObesity Drug Watch: AstraZeneca says its experimental once-daily oral weight-loss pill elecoglipron delivered dose-dependent results in a Phase 2 trial, with the top dose averaging 10.5% weight loss after 26 weeks versus 0.6% on placebo, raising the stakes in the race for easier-to-take GLP-1-style obesity treatments. Light Pollution & Health: A Nature study using NASA satellite images reports light pollution fell in Europe overall and dropped sharply in France (-33%), tied to street-lighting policies aimed at protecting nocturnal biodiversity and cutting energy use, while researchers note sleep-impact risks remain a concern. Global Alcohol Shift: IWSR data shows spirits overtook wine in global volume for the first time since 1990, while no- and low-alcohol beer is expected to double its share of the beer market by 2033. Hospitality & Food Culture: A travel piece highlights “clean plate” norms across much of Europe versus different expectations in China, plus guidance on dining etiquette to avoid awkward moments abroad. World Cup Food & Drink Angle: Coverage from Houston and beyond focuses on match-day logistics and fan culture, with stadium and venue changes shaping what visitors eat and drink during the tournament.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/af9c6fb4-2b61-4367-852e-7237ba1d9bc4/north-america-gastrointestinal-endoscopy-devices-market-size-2025-to-2035-usd-billion-.png)
